Mode
Text Size
Log in / Sign up

Elevated peripheral blood C-reactive protein levels are associated with posttraumatic stress disorderHigher Inflammation Markers Linked to Posttraumatic Stress Disorder

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that elevated peripheral blood CRP is associated with PTSD, though the specific nature of this inflammation remains unclear.

The study investigated the association between peripheral blood C-reactive protein (CRP) levels and posttraumatic stress disorder (PTSD). By comparing patients with PTSD against healthy controls across multiple reports, researchers aimed to determine if inflammatory markers are elevated in this population. The analysis found that patients with PTSD exhibited significantly higher concentrations of CRP in peripheral blood and serum compared to the control group.

However, the findings were less consistent when stratified by specific variables. While female participants showed significantly elevated levels, results for male participants and plasma samples did not reach statistical significance. These variations suggest that biological sex or the specific medium used for testing may influence the observed inflammatory markers in PTSD patients.

A primary limitation noted by the authors is the lack of data regarding the time elapsed since the traumatic event. Consequently, it is currently impossible to determine whether the observed CRP elevations represent an acute phase response to recent trauma or a state of chronic inflammation associated with long-term PTSD. Clinicians should view these findings as evidence of an inflammatory association while remaining cautious about the underlying mechanism.

Researchers analyzed data from 32 different studies involving over 2,600 people with posttraumatic stress disorder (PTSD) and more than 8,000 healthy individuals. The study looked specifically at C-reactive protein (CRP), which is a substance in the blood that indicates inflammation.

The results showed that people with PTSD had significantly higher levels of CRP in their peripheral blood and serum compared to those without the condition. Interestingly, these higher levels were particularly noticeable in women. However, the difference was not statistically significant when looking only at plasma or specifically at men's samples.

Because the study did not track how much time had passed since a person experienced a trauma, it is unclear if these high levels represent a long-term state or a short-term reaction to recent stress. This finding shows a link between inflammation and PTSD, but more research is needed to understand exactly how this process works in the body.

What this means for you:
People with PTSD often show higher blood inflammation markers, though results vary by gender and sample type.

Common questions

What is C-reactive protein and why does it matter?

C-reactive protein (CRP) is a substance found in the blood that serves as a marker for inflammation. This study found that people with PTSD had significantly higher levels of CRP in their peripheral blood and serum compared to healthy individuals.

Do these findings differ between men and women?

The results showed significant differences based on gender and sample type. While women with PTSD showed significantly elevated CRP levels, the difference was not statistically significant in samples from men or in plasma measurements.

Does this mean inflammation causes PTSD?

The study shows a link between higher CRP levels and PTSD, but it does not prove that one causes the other. Because researchers did not have data on when the trauma occurred, they cannot say if the inflammation is a chronic state or an acute response.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
BackgroundPosttraumatic stress disorder (PTSD) was reported to be associated with inflammation. C-reactive protein (CRP) is an important biomarker of systemic inflammation. A series of studies have reported the change of peripheral blood CRP in PTSD. However, the results were controversial. Our aim was to evaluate whether abnormal peripheral blood CRP levels was associated with PTSD using a systematic review and meta-analysis method.MethodsFive databases (PubMed, Embase, Web of Science, Cochrane library and PsycINFO) were searched for available articles published up to 2 May, 2026. Hedges’ g with its corresponding 95% confidence interval (CI) was selected to assess the group difference in CRP concentrations, a random effects model or fixed effects model were selected according to the results of heterogeneity test.ResultsA total of 32 studies (39 reports) with 2667 PTSD patients and 8166 controls were included in our analysis. Significantly elevated peripheral blood CRP levels were found in PTSD participants compared with controls (Hedges’ g = 0.188, 95% CI 0.080 to 0.296, p = 0.001). Subgroup analysis showed a significant elevation in serum (Hedges’ g = 0.208, 95% CI 0.049 to 0.368, p = 0.01) and the female groups (Hedges’ g = 0.446, 95% CI 0.043 to 0.849, p = 0.03), but not in plasma (Hedges’ g = 0.140, 95% CI –0.051 to 0.331, p = 0.151) and the male groups (Hedges’ g = 0.143, 95% CI –0.008 to 0.294, p = 0.063), suggesting that the type of biological sample and gender may influence the observed association. Other subgroup analyses (e.g., control type, PTSD type, detection method and traumatic type) generally showed consistent results. The significance of the association between peripheral blood CRP concentration and PTSD remained unchanged after excluding studies outside the Galbraith plot. Baujat plot identified three studies contribute most to the heterogeneity. Removing any single study verified by sensitivity analysis did not reverse the association. Meta-regression analysis revealed that the association was moderated by mean body mass index (BMI). No obvious publication bias was found in the meta-analysis.ConclusionThis meta-analysis provides evidence for elevation of peripheral blood CRP in PTSD. However, due to the lack of data on time since trauma in the included studies, the current findings cannot differentiate whether the elevated CRP is an acute phase response to the traumatic event itself or the inflammatory state of chronic PTSD. More well-designed longitudinal studies are required to demonstrate this conclusion in the future.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.